Alterity Therapeutics got a US patent for ATH434, its main drug for brain disease.
Why it mattersPatent protection helps the company compete and makes the drug more valuable.
Free. Be genuinely informed in 5 minutes a day. No signup, no noise.
Get the free app, read the whole feed
InSnip turns the day's news into short, source-backed snippets with a plain why it matters line. The signal, not the scroll.